Displaying archives for 2014 July:

Lung Congress to Offer Thorough Review of Latest Research Findings

Posted by Samantha Powell on July 31st, 2014 |

The 15th Annual International Lung Cancer Congress, which began today in Huntington Beach, California and will continue through Saturday, will offer an array of information presented by multidisciplinary experts—in a brand-new format. “It’s set up to be a think tank, with 200 lung cancer experts plus participants [from the audience endeavoring] to digest what was […]

Lung Cancer Early Detection Test

Posted by Samantha Powell on July 30th, 2014 |

Each year lung cancer kills half of those diagnosed— more people than breast, prostate and colon cancers combined. There’s been no agreement on the best early detection screening for lung cancer, but a trial by the National Cancer Institute has led to new recommendations. They don’t come as any surprise to one local lung specialist […]

Foundation Medicine Releases Enhanced Version of FoundationOne(R)

Posted by Samantha Powell on July 29th, 2014 |

Foundation Medicine, Inc. (NASDAQ: FMI) today announced the launch of an updated FoundationOne(R), incorporating several enhancements that reflect the company’s ongoing commitment to innovation in patient care. The latest version of the most comprehensive genomic profile validated for clinical use features advancements to several components of this unique end-to-end solution, and will be commercially available, […]

Penn team makes cancer glow to improve surgical outcomes

Posted by Samantha Powell on July 29th, 2014 |

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence. With a new technique, researchers at the University of Pennsylvania have established a new strategy to help […]

A universal blood test for cancer is in the works

Posted by Samantha Powell on July 29th, 2014 |

A universal blood test for cancer is in the works. Researchers from the University of Bradford in England devised a blood test that can be used to detect whether or not people have cancer. (Take a look at the gallery above to dispel some of the myths surrounding cancer.) The test would allow doctors to […]

NCCN Offers Free Webinars for Patients With Non-Small Cell Lung Cancer

Posted by Samantha Powell on July 28th, 2014 |

On Thursday, July 24, 2014, the National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation®, hosted its first of two free patient information webinars titled, “Know What Your Doctors Know: Non-Small Cell Lung Cancer Treatment.” Registration is still open for the second NCCN patient information webinar, which is scheduled for Saturday, August […]

Ne-Yo, Natasha Bedingfield Play Fenway, Help Raise $1.3 Million for Carver Man

Posted by Samantha Powell on July 27th, 2014 |

On Sunday, July 27, Fenway Park was transformed from into a support center for Dan Grimes, a 42-year-old Carver resident who was recently diagnosed with stage IV lung cancer. Performers Ne-Yo and Natasha Bedingfield teamed up with Grimes’ employer, Healthbridge, and its parent company, CareOne, for a special concert inside of the Gate D concourse […]

ACR statement on cancer study regarding patient anxiety from CT lung cancer screening

Posted by Samantha Powell on July 25th, 2014 |

Anxiety regarding inconclusive cancer screening test results among some patients is real and is only natural. However, as evidenced by Gareen et al, published July 25 inCancer, the incidence and effects of anxiety associated with false positive or other results of computed tomography (CT) lung cancer screening exams are far less than claimed by some […]

Foundation Medicine Partners with the Addario Lung Cancer Medical Institute for Innovative Prospective Study Linking the Genomic Drivers of Lung Cancer in Young Adults with Treatment Options

Posted by Samantha Powell on July 23rd, 2014 |

Foundation Medicine, Inc. (NASDAQ: FMI) today announced that it has partnered with the Addario Lung Cancer Medical Institute (ALCMI) and Bonnie J. Addario Lung Cancer Foundation (ALCF) to launch a first of its kind, multi-center, international prospective study, the Genomics of Young Lung Cancer. This study aims to better inform treatment decisions in young adults […]

Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic Immuno-Oncology Collaboration in Japan, South Korea and Taiwan

Posted by Samantha Powell on July 23rd, 2014 |

Bristol-Myers Squibb Company (NYSE:BMY) and Ono Pharmaceutical Co., Ltd. (“Ono”) have signed a strategic collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea and Taiwan. As part of the agreement, Bristol-Myers Squibb and Ono […]